Buscar

Mostrando ítems 1-10 de 150

Development of a DNA-based vaccine strategy against bovine papillomavirus infection, involving the E5 or L2 gene

Lima, E. G.; Lira, R. C.; Jesus, A. L. S.; Dhalia, R.; Freitas, A. C. (Genetics and Molecular Research, 2017)

Freqüência de papilomavírus humano em lesões epiteliais de boca

Lazzari, Carmen Maria (2007)

Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults.

Moreira Júnior, Edson Duarte; Palefsky, Joel M; Giuliano, Anna R; Goldstone, Stephen; Aranda, Carlos; Jessen, Heiko; Hillman, Richard J; Ferris, Daron G; Coutlee, Francois; Vardas, Eftyhia; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M; Guris, Dalya; Garner, Elizabeth I. O (Taylor & Francis, 2014)

Tratamento do papiloma vírus humano na infância com creme de imiquimode a 5%

BRANDT, Hebert Roberto Clivati; FERNANDES, Juliana Dumêt; PATRIOTA, Regia Celli Ribeiro; CRIADO, Paulo Ricardo; BELDA JUNIOR, Walter (Sociedade Brasileira de Dermatologia, 2010)

Lesões decorrentes da infecção pelo papilomavírus humano na infância, em especial as verrugas anogenitais, são um importante problema epidemiológico e terapêutico. O tratamento das verrugas anogenitais na infância é um ...

Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males.

Goldstone, Stephen; Jessen, Heiko; Palefsky, Joel M; Giuliano, Anna R; Moreira Júnior, Edson Duarte; Vardas, Eftyhia; Aranda, Carlos; Hillman, Richard J; Ferris, Daron G; Coutlee, Francois; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M; Guris, Dalya; Garner, Elizabeth I. O (Elsevier Ltd, 2014)

Prognostic evaluation of DNA index in HIV-HPV co-infected women cervical samples attending in reference centers for HIV-AIDS in Recife

Martins, Albert Eduardo Silva; Lucena-Silva, Norma; Garcia, Renan Gomes; Welkovic, Stefan; Barbosa, Aureliana; Menezes, Maria Luiza Bezerra; Tenório, Terezinha; Maruza, Magda; Ximenes, Ricardo A. A. (2017)

Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.

Hillman, Richard J; Giuliano, Anna R; Palefsky, Joel M; Goldstone, Stephen; Moreira Júnior, Edson Duarte; Vardas, Eftyhia; Aranda, Carlos; Jessen, Heiko; Ferris, Daron G; Coutlee, Francois; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M; Guris, Dalya; Garner, Elizabeth I. O (American Society for Microbiology, 2014)

P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions.

Queiroz, Conceição; Silva, Tânia Maria Correia; Alves, Venâncio Avancini Ferreira; Villa, Luisa L.; Costa, Maria Cecília; Travassos, Ana Gabriela Álvares; Araújo Filho, José Bouzas; Studart, Eduardo; Cheto, Tatiana; Freitas, Luiz Antonio Rodrigues de (Elsevier, 2014)

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

The Future II Study Group*; Moreira Júnior, Edson Duarte (Massachusetts Medical Society, 2015)

Doença cervical pré-invasiva e câncer cérvico-uterino em adolescentes brasileiras: prevalência e fatores associadosPre-invasive cervical disease and uterine cervical cancer in Brazilian adolescents: prevalence and related factors

Monteiro, Denise Leite Maia; Trajano, Alexandre José Baptista; Silva, Kátia Silveira da; Russomano, Fábio Bastos (2010)

1
2
3
4
. . .
15